• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Salk scientist Diana Hargreaves named Pew-Stewart Scholar for innovative cancer research

Bioengineer by Bioengineer
June 14, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Salk Institute

LA JOLLA – (June 14, 2019) Diana Hargreaves, an assistant professor in Salk’s Molecular and Cell Biology Laboratory, has been named a 2019 Pew-Stewart Scholar for Cancer Research as part of a partnership between the Pew Charitable Trusts and the Alexander and Margaret Stewart Trust. The scholars each receive $300,000 over four years to support their work focused on a better understanding of the causes, diagnosis and treatment of cancer.

“Diana is pushing the boundaries of cancer research by studying the protein complexes that organize our DNA, which are frequently mutated in cancer,” says Salk President Rusty Gage. “We are excited and proud to have her groundbreaking work recognized by the Pew Charitable Trusts and the Alexander and Margaret Stewart Trust.”

Hargreaves, who holds the Richard Heyman and Anne Daigle Endowed Developmental Chair, is one of the faculty involved in the Salk Conquering Cancer Initiative, aiming to uncover new insights into the deadliest cancers. She studies epigenetic regulators, proteins that work to make specific regions of the genome more or less accessible for gene transcription. Unlike our fixed genome, the epigenome is dynamic, allowing cells to respond to developmental and external environmental cues. For example, she investigates a subunit of an epigenetic regulator (the SWI/SNF complex) called ARID1A, which can be mutated in solid tumors such as in ovarian, bladder and colorectal cancer. By understanding the proteins’ roles in driving cancer, she aims to find ways to reverse tumor progression.

Hargreaves’ work extends to include many different angles of cancer initiation and progression. As a Pew-Stewart Scholar, she proposes to study the role of the SWI/SNF complex and other epigenetic regulators in controlling the activation of immune cells that infiltrate cancers. For instance, she seeks to examine the possibility of reprogramming tumor-associated macrophages (TAMs) to alert the immune system of a tumor instead of promoting the spread of cancer. Her studies have the potential to enhance the current state of cancer immunotherapy by uncovering a new set of therapeutic targets designed to boost immune system defenses against tumors.

The Pew-Stewart Scholars Program for Cancer Research is a national initiative designed to support promising early career scientists whose research will accelerate discovery and advance progress to a cure for cancer. The Stewart Trust has invested in innovative, cutting-edge cancer research and scientists for over 15 years. Through this partnership, The Pew-Stewart Scholars for Cancer Research have tremendous potential to solve some of cancer’s weightiest challenges.

###

About the Trusts:

The Pew Charitable Trusts is driven by the power of knowledge to solve today’s most challenging problems. Learn more at pewtrusts.org.

The Alexander and Margaret Stewart Trust is a charitable foundation supporting nonprofit organizations that research, treat, and prevent cancer and pediatric illnesses. Learn more at stewart-trust.org.

About the Salk Institute for Biological Studies:

Every cure has a starting point. The Salk Institute embodies Jonas Salk’s mission to dare to make dreams into reality. Its internationally renowned and award-winning scientists explore the very foundations of life, seeking new understandings in neuroscience, genetics, immunology, plant biology and more. The Institute is an independent nonprofit organization and architectural landmark: small by choice, intimate by nature and fearless in the face of any challenge. Be it cancer or Alzheimer’s, aging or diabetes, Salk is where cures begin. Learn more at: salk.edu.

Media Contact
Salk Communications
[email protected]

Original Source

https://www.salk.edu/news-release/salk-scientist-diana-hargreaves-named-pew-stewart-scholar-for-innovative-cancer-research/

Tags: BiologycancerCell BiologyGeneticsMedicine/HealthMolecular Biology
Share19Tweet8Share2ShareShareShare2

Related Posts

Medicaid Innovation Models Enhance Maternal Care, Highlighting the Importance of Strategic Design

October 8, 2025

AI Mimics Pathologists for Clear Prostate Cancer Grading

October 8, 2025

Dual HDAC/PI3K Inhibitors Trigger Apoptosis in p53-Mutant Lymphoma

October 8, 2025

Sickle Cell Disease Patients Experience Significant Delays in Emergency Department Pain Management

October 8, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1098 shares
    Share 438 Tweet 274
  • New Study Reveals the Science Behind Exercise and Weight Loss

    100 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    95 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    79 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Scientists Develop Radiotheranostic Strategy to Target Aggressive Cancers

Harnessing Alcohol Dehydrogenases for Sustainable Amide and Thioester Synthesis

How Smoking and Biological Sex Influence Healthy Bladder Tissue Development: New Insights into Cancer Risk

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.